Dyne Therapeutics (DYN)
(Delayed Data from NSDQ)
$44.88 USD
-1.65 (-3.55%)
Updated Aug 26, 2024 04:00 PM ET
After-Market: $44.89 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Earnings News For DYN
-
Dyne Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
-
Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
-
Dyne Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
-
Dyne Therapeutics Reports Third Quarter 2023 Financial Results and Provides Update on Significant Progress for ACHIEVE and DELIVER Trials and Upcoming Clinical Milestones
-
Dyne Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
-
Dyne Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights
-
Dyne Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
-
Dyne Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
-
Dynegy's (DYN) Q2 Loss Wider than Expected, Revenues Beat